Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cor van den Bos

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Cancers|December 16, 2020
Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial)Mirjam Esther van de Velde, Gertjan J L Kaspers, Floor C H Abbink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2018
Peripheral Stem Cell Apheresis is Feasible Post <sup>131</sup>Iodine-Metaiodobenzylguanidine-Therapy in High-Risk Neuroblastoma, but Results in Delayed Platelet ReconstitutionKathelijne C J M Kraal, Ilse Timmerman, Hannah M Kansen, et al.
Cancer Medicine|September 21, 2023
Randomized controlled trial on the effect of 1-hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis)Aniek Uittenboogaard, Marleen H van den Berg, Floor C H Abbink, et al.
Stem Cells and Development|January 16, 2025
PEGylated Granulocyte Colony-Stimulating Factor and Plerixafor Enhance Autologous Stem and Progenitor Cell Mobilization and Transplantation in Pediatric PatientsCaroline Hochheuser, Maria L Rozeman, Nina Kunze, et al.
JAMA|June 28, 2007
Medical assessment of adverse health outcomes in long-term survivors of childhood cancerMaud M Geenen, Mathilde C Cardous-Ubbink, Leontien C M Kremer, et al.
Cancers|July 9, 2020
Population Pharmacokinetics of Vincristine Related to Infusion Duration and Peripheral Neuropathy in Pediatric Oncology PatientsMirjam Esther van de Velde, John Carl Panetta, Abraham J Wilhelm, et al.
Cancer Medicine|November 2, 2021
The association between vincristine-induced peripheral neuropathy and health-related quality of life in children with cancerMirjam E van de Velde, Marleen H van den Berg, Gertjan J L Kaspers, et al.
Cancer|December 7, 2018
A multicenter study of patients with multisystem Langerhans cell histiocytosis who develop secondary hemophagocytic lymphohistiocytosisDeepak Chellapandian, Melissa R Hines, Rui Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2007
Long term survivors of childhood cancer: cure and care. The Erice statementRiccardo Haupt, John J Spinetta, Irina Ban, et al.
Cancers|July 27, 2022
Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology PatientsMirjam E van de Velde, Aniek Uittenboogaard, Wenjian Yang, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Cancers|December 16, 2020
Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial)Mirjam Esther van de Velde, Gertjan J L Kaspers, Floor C H Abbink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2018
Peripheral Stem Cell Apheresis is Feasible Post <sup>131</sup>Iodine-Metaiodobenzylguanidine-Therapy in High-Risk Neuroblastoma, but Results in Delayed Platelet ReconstitutionKathelijne C J M Kraal, Ilse Timmerman, Hannah M Kansen, et al.
Cancer Medicine|September 21, 2023
Randomized controlled trial on the effect of 1-hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis)Aniek Uittenboogaard, Marleen H van den Berg, Floor C H Abbink, et al.
Stem Cells and Development|January 16, 2025
PEGylated Granulocyte Colony-Stimulating Factor and Plerixafor Enhance Autologous Stem and Progenitor Cell Mobilization and Transplantation in Pediatric PatientsCaroline Hochheuser, Maria L Rozeman, Nina Kunze, et al.
JAMA|June 28, 2007
Medical assessment of adverse health outcomes in long-term survivors of childhood cancerMaud M Geenen, Mathilde C Cardous-Ubbink, Leontien C M Kremer, et al.
Cancers|July 9, 2020
Population Pharmacokinetics of Vincristine Related to Infusion Duration and Peripheral Neuropathy in Pediatric Oncology PatientsMirjam Esther van de Velde, John Carl Panetta, Abraham J Wilhelm, et al.
Cancer Medicine|November 2, 2021
The association between vincristine-induced peripheral neuropathy and health-related quality of life in children with cancerMirjam E van de Velde, Marleen H van den Berg, Gertjan J L Kaspers, et al.
Cancer|December 7, 2018
A multicenter study of patients with multisystem Langerhans cell histiocytosis who develop secondary hemophagocytic lymphohistiocytosisDeepak Chellapandian, Melissa R Hines, Rui Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2007
Long term survivors of childhood cancer: cure and care. The Erice statementRiccardo Haupt, John J Spinetta, Irina Ban, et al.
Cancers|July 27, 2022
Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology PatientsMirjam E van de Velde, Aniek Uittenboogaard, Wenjian Yang, et al.
Pageof 7